Immunoclin Overview
- Founded
- 2000
- Status
- Out of Business
- Employees
- 2
- Latest Deal Type
- Out of Business
- Financing Rounds
- 2
- Investments
- 1
Immunoclin General Information
Description
Operator of a healthcare company based in Washington DC, United States. The company specializes in developing personalized and preventive strategies to fight inflammatory conditions that are the underlying cause of pathologies in multiple human conditions.
Contact Information
Website
Formerly Known As
Pharma Investing News
Ownership Status
Out of Business
Financing Status
Corporation
Primary Industry
Drug Discovery
Primary Office
- 1420 North Street
- Suite 102
- Washington DC, 20005
- United States
Immunoclin Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Immunoclin‘s full profile, request access.
Request a free trialImmunoclin Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialImmunoclin Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000000 0 | 18-Dec-2013 | 000000000000000000 | Media and Information Services (B2B) | 0000000 0000 00.0 |
Immunoclin Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 000000000 0 | Media and Information Services (B2B) | Beverly Hills, CA | 0000 |